TNFR1 predominantly augments pro-inflammatory response, demyelination and neuronal death, whereas TNFR2 restrains pro-inflammatory milieu and promotes the initiation of tissue regeneration and remyelination in animal models of ischemia or multiple sclerosis [51–55]. Here, TNFRSF1B is linked to multiple sclerosis.